Medical Devices Global

Global Carrier Screening Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Global Carrier Screening Market Industry Trends and Forecast to 2034: Segmented by (Test, Condition, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Global · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $2.66 Bn Placeholder estimate
Estimate 2025 $2.96 Bn Placeholder estimate
Projected 2034 $7.56 Bn 155.8% Adds $4.61 Bn over 9 forecast years
CAGR 2025–2034 11.0% Faster than 65% of 173 Medical Devices markets here
Key players 5
  • Worldwide, the largest is US at $1.35 Bn.
  • Fastest growing: India at 14.4% a year.

Market size projection

Global

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$4.61 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Carrier Screening Market market size by year, Global
YearMarket sizeChange that yearSince 2025
2024 (estimate) $2.66 Bn — —
2025 (base) $2.96 Bn +$293.0 Mn —
2026 (forecast) $3.28 Bn +$325.3 Mn +11%
2027 (forecast) $3.64 Bn +$361.1 Mn +23.2%
2028 (forecast) $4.04 Bn +$400.8 Mn +36.8%
2029 (forecast) $4.49 Bn +$444.9 Mn +51.8%
2030 (forecast) $4.98 Bn +$493.8 Mn +68.5%
2031 (forecast) $5.53 Bn +$548.1 Mn +87%
2032 (forecast) $6.14 Bn +$608.4 Mn +107.6%
2033 (forecast) $6.81 Bn +$675.3 Mn +130.5%
2034 (forecast) $7.56 Bn +$749.6 Mn +155.8%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global (this report) $2.96 Bn
  2. North America $1.60 Bn
  3. US $1.35 Bn
  4. APAC $617.9 Mn
  5. Europe $487.3 Mn
  6. China $250.5 Mn
  7. Canada $228.6 Mn
  8. Japan $194.1 Mn
  9. Middle East $126.2 Mn
  10. Germany $112.3 Mn
  11. Latin America $116.8 Mn
  12. Brazil $83.1 Mn
  13. Italy $80.3 Mn
  14. UK $77.7 Mn
  15. France $78.2 Mn
  16. Spain $54.5 Mn
  17. Ecuador $53.9 Mn
  18. India $54.8 Mn
  19. Africa $49.4 Mn
  20. Saudi Arabia $46.3 Mn
  21. Mexico $43.9 Mn
  22. New Zealand $33.1 Mn
  23. Australia $32.0 Mn
  24. Russia $26.8 Mn
  25. South Africa $18.2 Mn
  26. UAE $15.2 Mn
  27. Egypt $9.6 Mn
  28. Philippines $6.8 Mn
  29. Hong Kong $5.5 Mn
  30. Malaysia $4.9 Mn
  31. Singapore $3.7 Mn
  32. Thailand $3.5 Mn
  33. Kenya $2.0 Mn

Report snapshot

Global Carrier Screening Market Analysis at a glance
Market size, 2025$2.96 Bn placeholder estimate
Forecast, 2034$7.56 Bn placeholder estimate
Growth (CAGR), 2025–203411.0% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTest, condition and end user (see all)
Key playersMyriad Genetics, Inc., Natera, Invitae, Sema4 (GeneDx), Fulgent Genetics (see all)
Regulator worldwideIMDRFSource: International Medical Device Regulators Forum. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Global Carrier Screening Market Analysis Executive Summary

Carrier screening checks future parents for gene changes they could pass on, such as for cystic fibrosis or spinal muscular atrophy.

Key segments of the carrier Screening market include test (Expanded Panels and Targeted Screening) and condition (Cystic Fibrosis, SMA and Thalassemia).

Bar chart: Global Carrier Screening market size, 2024–2034, placeholder estimates. $2.66 Bn in 2024, $2.96 Bn in 2025 and $7.56 Bn in 2034, 11.0% CAGR.
Global Carrier Screening market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Global Carrier Screening Market Dynamics

Market Growth Drivers

The falling cost of DNA sequencing, more targeted medicines, large national genome programmes and growing use of genetic results in everyday care are driving the carrier Screening market.

Opportunity

Routine use of genomics in screening, pharmacy and primary care gives the carrier Screening market large room to grow.

Market Restraints

Data privacy concerns, limited reimbursement for some tests, shortages of genetic counsellors and complex data analysis hold back the carrier Screening market.

Competitive Landscape for Carrier Screening Market in Global

The carrier Screening market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Carrier Screening Market in Global

Carrier Screening worldwide: rules and payment

There is no single global regulator; the International Medical Device Regulators Forum (IMDRF) helps national regulators align their device rules.⁠[1] WHO reports that 4.5 billion people were not fully covered by essential health services in 2021.⁠[2]

[1] International Medical Device Regulators Forum. Checked 14 Nov 2026.

[2] World Health Organization, universal health coverage. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how carrier Screening products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Global.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Carrier Screening right now, from free public sources.

Latest research 837 papers since 2021 (worldwide)

  1. Detection of Silent Carriers of Spinal Muscular Atrophy: A Survey of Clinical Practice and Recommendations for Screening. Twin research and human genetics : the official journal of the International Society for Twin Studies, 2026
  2. [System construction and clinical practice of genetic disease carrier screening in donor sperm-assisted reproduction]. Zhonghua nan ke xue = National journal of andrology, 2026
  3. Reproductive carrier screening: perspectives for a future implementation in Germany. Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V, 2026
  4. Population-specific differences in ClinVar pathogenic and likely pathogenic variants of epilepsy-associated genes between East Asian and non-finnish European populations: a nucleotide-resolved gnomAD v4.1.1 analysis. Frontiers in genetics, 2026
  5. Genetic Landscape and Carrier Screening of Deafness-Associated Genes in a Prenatal Cohort from Fujian, China. International journal of women's health, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Carrier Screening in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Carrier Screening market worldwide?
Placeholder estimate: about $2.96 Bn in 2025, rising to about $7.56 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Carrier Screening market worldwide growing?
Placeholder estimate: about 11.0% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Carrier Screening market report cover?
The report splits the market by test (Expanded Panels, Targeted Screening), condition (Cystic Fibrosis, SMA, Thalassemia, Fragile X) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Carrier Screening market?
Key players include Myriad Genetics, Inc., Natera, Invitae, Sema4 (GeneDx) and Fulgent Genetics.
What is driving the Carrier Screening market?
The falling cost of DNA sequencing, more targeted medicines, large national genome programmes and growing use of genetic results in everyday care are driving the carrier Screening market.
Who regulates Carrier Screening worldwide?
There is no single global regulator; the International Medical Device Regulators Forum (IMDRF) helps national regulators align their device rules. Source: International Medical Device Regulators Forum. Checked 14 Nov 2026.
How is healthcare paid for worldwide?
WHO reports that 4.5 billion people were not fully covered by essential health services in 2021. Source: World Health Organization, universal health coverage. Checked 14 Nov 2026.
How much research is published on Carrier Screening?
PubMed lists 837 papers on Carrier Screening added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Carrier Screening in Global? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Women's Health Supplements: A Growing FocusAnaemia affects about half a billion women worldwide, and folic acid before pregnancy prevents serious birth… Iron Supplements and the Fight Against AnaemiaIron supplements are the first line against anaemia. Why taking them is the hard part, and how the market is… Dermatology Diagnostics: AI and Skin HealthSkin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions…
Back to Catalogue
Keep exploring

Related Medical Devices reports in Global

See all
Same topic, other categories

Related on genomics and maternal

See the topic